Skip to main content

Table 5 Predictors of annual patient cost of end-stage renal disease

From: Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria

Parameter

B

Std. Error

95% CI

Hypothesis Test

Lower

Upper

Wald Chi-Square

Sig.

 

(Intercept)

7.22

0.40

6.44

8.00

327.93

< 0.001

Age

≥ 60

0.08

0.22

-0.36

0.51

0.12

0.730

 

40–59

-0.37

0.21

-0.78

0.04

3.10

0.078

 

< 40

0a

     

Marital status

Single

0.16

0.34

-0.50

0.82

0.22

0.636

 

Married

0.23

0.29

-0.35

0.80

0.59

0.442

 

Widowed

-0.11

0.34

-0.77

0.55

0.10

0.748

 

Divorced/Separated

0a

     

Residence

Others

0.59

0.20

0.19

0.99

8.50

0.004*

 

Satellite

0.16

0.13

-0.10

0.42

1.44

0.230

 

Nearby towns

0.01

0.17

-0.32

0.35

0.01

0.934

 

Municipality

0a

     

Education

SSCE and below

-0.28

0.15

-0.58

0.02

3.29

0.069

 

Higher education

0a

     

Wealth index

Poor

-0.41

0.29

-0.98

0.17

1.91

0.167

 

Middle

-0.44

0.28

-0.98

0.10

2.50

0.114

 

Rich

0a

     

Health insurance

No

0.27

0.14

-0.01

0.55

3.62

0.057

 

Yes

0a

     

Facility type

Private

0.75

0.15

0.46

1.05

24.84

< 0.001*

 

PPP

0.09

0.17

-0.26

0.43

0.24

0.621

 

Public

0a

     

Comorbidity

No

-0.23

0.20

-0.63

0.17

1.27

0.259

 

Yes

0a

     

Number of HD Sessions

> 6

0.99

0.18

0.63

1.34

29.96

< 0.001*

4–6

0.19

0.21

-0.23

0.60

0.77

0.380

0–3

0a

     
 

(Scale)

0.554b

0.05

0.46

0.66

  
  1. a. Reference category. *Significant at p-value < 0.05
  2. b. Maximum likelihood estimate